- 2019 - 2022 免疫チェックポイント・タンパク質PD-L1を分子標的とした新規免疫治療法の開発
- 2016 - 2019 Membrane trafficking of PD-L1 which is regulated by CUL3-BTBP
- 2014 - 2018 Molecular mechanism elucidation of gastric and intestinal differentiation and development of differentiation-inducing therapy against stem cell
- 2013 - 2016 Advances in refractory IBD treatment: a new therapeutic target, Annexin A2
- 2012 - 2015 Development of membrane protein function analysis and the new suppression mediated by the tumor necrosis factor precursor and producing enzyme
- 2011 - 2013 The analysis of the shift from gastric to intestinal phenotype of stem cell in the stomach mucosa
- 2010 - 2012 Potential of new anti-cancer agents targeting the nuclear translocation signaling of HB-EGF C-terminal fragments
- 2009 - 2011 To clarify the mechanism that C terminal fragments of EGFR ligand cause nuclear export of transcriptional repressors
- 炎症性サイトカイン・上皮増殖因子(EGFファミリー)を介した発癌メカニズムの解明
- 炎症から発がんのメカニズム
- 炎症性腸疾患治療の開発
Show all